Paul Tudor Jones II started to build up the position in Enzon Pharmaceuticals in Q4 2013 and continued to invest until Q3 2014. Since then they sold 48 Thousand shares. The investor sold all their shares in Q4 2016 and doesn't own any shares in Enzon Pharmaceuticals anymore.